Primary Recipient

CEDARS-SINAI MEDICAL CENTER

Amount

$591,999.00

Award Date

9/02/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Diabetic retinopathy (DR) is the leading cause of blindness in people aged 20-74 years in the United States. Although retinopathy is more common in type 1 diabetes, the majority of new cases are due to type 2 diabetes (T2DM). The socioeconomic cost of DR

Vendors Connected to Award

Vendor	Role	Amount
Illumina Inc.	Primary vendor	$43,954.91
Illumina Inc.	Primary vendor	$284,472.00
Illumina Inc.	Primary vendor	$26,804.97